MRC Announces the Publication of its Research Report Global Influenza Vaccine Market 2018-2022
MRC recognizes the following companies as the key players in the global influenza vaccine market: AstraZeneca, CSL, GlaxoSmithKline, and Sanofi.
Other Prominent Vendors in the market are: Altimmune, BionVax, FluGen, FOLIA BIOTECH, Genentech, Green Cross, Medicago, Moderna Therapeutics, Novavax, Shijiazhuang Yiling Pharmaceutical, SK Chemicals, UNM Pharma, Vaccitech, Vaxart, Vaxine Pty, and Visterra.
Commenting on the report, an analyst from MRC’s team said: “The latest trend gaining momentum in the market is development of strong pipeline. The increasing R&D programs is significantly influencing the growth of the pipeline molecule count in the influenza market. Universal influenza vaccine initiative (UIVI) is a program conducted to combat the challenges in developing a vaccine that broadly protects against all types of influenza viruses. Furthermore, the number of clinical trials for developing a vaccvine for treating influenza is steadily increasing. The launch of all molecules in phase III will generate significant revenue on completion of the clinical trials.
According to the report, one of the major drivers for this market is rising awareness about influenza vaccination. With the growing support of both government and non-government bodies, the awareness about influenza virus is rising across the globe. Both the government and non-government organizations are taking adequate initiatives to prevent diseases. To educate people about the influenza virus and the importance of influenza vaccination, CDC conducts national vaccination week. WHO has developed generic campaign materials to support the campaign. Such initiatives will help people gain more knowledge about the preventive measures available against influenza, in turn, driving the demand for these vaccines.
Get Sample Pages of the report at https://marketreportscenter.com/request-sample/573633
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
About Influenza Vaccine
Influenza is an infectious disease caused by the influenza virus. It is also known as flu. Influenza virus is a ribonucleic acid (RNA) virus that belongs to Orthomyxoviridae family. It is a helical shaped, single-stranded virus. Influenza A virus affects people of all age groups and causes moderate to severe illness, while the infection due to influenza B virus results in milder disease and affects pediatrics primarily. Human illness due to influenza C is rare. Influenza C illness might be due to subclinical cases. Hence, it does not cause epidemic diseases. Influenza has emerged as a severe health concern globally. The market encompasses both live attenuated as well as recombinant influenza vaccines for the prevention of influenza. The major factors that lead to the market growth include the need for annual vaccination and government initiatives to improve awareness about vaccination.
MRC’s analysts forecast the global influenza vaccine market to grow at a CAGR of 7.23% during the period 2018-2022.
Check the discount on the report at https://marketreportscenter.com/request-discount/573633
Covered in this report
The report covers the present scenario and the growth prospects of the global influenza vaccine market for 2018-2022. To calculate the market size, the report considers the revenue generated from the sales of influenza vaccine.
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
MRC's report, Global Influenza Vaccine Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
AstraZeneca
CSL
GlaxoSmithKline
Sanofi
Other prominent vendors
Altimmune
BionVax
FluGen
FOLIA BIOTECH
Genentech
Green Cross
Medicago
Moderna Therapeutics
Novavax
Shijiazhuang Yiling Pharmaceutical
SK Chemicals
UNM Pharma
Vaccitech
Vaxart
Vaxine Pty
Visterra.
Market driver
Rising awareness about influenza vaccination
For a full, detailed list, view our report
Market trend
Development of strong pipeline
For a full, detailed list, view our report
Review the summary and complete table of content at https://marketreportscenter.com/reports/573633/global-influenza-vaccine-market-2018-2022
About Market Reports Center;
Market Reports Center is an e-commerce platform obliging the needs of knowledge workers, experts, professionals who are subject to market research information for their work, or to make strategic business decisions. We are dedicated to create a comprehensive offering of market research which is accurate, credible and affordable.
Market Reports Center currently has more than 3,00,000 plus titles and 40+ Publishers on our platform and growing consistently. We cover more than 35 industry verticals being: Automotive, Electronics, Manufacturing, Pharmaceuticals, Healthcare, Chemicals, Construction, Agriculture, Food, Beverages, Banking & Finance, Media and Government, Public Sector Studies.
Connect for more details:
Sam Collins
Market Reports Center
1-646-883-3044 (US)
MRC recognizes the following companies as the key players in the global influenza vaccine market: AstraZeneca, CSL, GlaxoSmithKline, and Sanofi.
Other Prominent Vendors in the market are: Altimmune, BionVax, FluGen, FOLIA BIOTECH, Genentech, Green Cross, Medicago, Moderna Therapeutics, Novavax, Shijiazhuang Yiling Pharmaceutical, SK Chemicals, UNM Pharma, Vaccitech, Vaxart, Vaxine Pty, and Visterra.
Commenting on the report, an analyst from MRC’s team said: “The latest trend gaining momentum in the market is development of strong pipeline. The increasing R&D programs is significantly influencing the growth of the pipeline molecule count in the influenza market. Universal influenza vaccine initiative (UIVI) is a program conducted to combat the challenges in developing a vaccine that broadly protects against all types of influenza viruses. Furthermore, the number of clinical trials for developing a vaccvine for treating influenza is steadily increasing. The launch of all molecules in phase III will generate significant revenue on completion of the clinical trials.
According to the report, one of the major drivers for this market is rising awareness about influenza vaccination. With the growing support of both government and non-government bodies, the awareness about influenza virus is rising across the globe. Both the government and non-government organizations are taking adequate initiatives to prevent diseases. To educate people about the influenza virus and the importance of influenza vaccination, CDC conducts national vaccination week. WHO has developed generic campaign materials to support the campaign. Such initiatives will help people gain more knowledge about the preventive measures available against influenza, in turn, driving the demand for these vaccines.
Get Sample Pages of the report at https://marketreportscenter.com/request-sample/573633
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
About Influenza Vaccine
Influenza is an infectious disease caused by the influenza virus. It is also known as flu. Influenza virus is a ribonucleic acid (RNA) virus that belongs to Orthomyxoviridae family. It is a helical shaped, single-stranded virus. Influenza A virus affects people of all age groups and causes moderate to severe illness, while the infection due to influenza B virus results in milder disease and affects pediatrics primarily. Human illness due to influenza C is rare. Influenza C illness might be due to subclinical cases. Hence, it does not cause epidemic diseases. Influenza has emerged as a severe health concern globally. The market encompasses both live attenuated as well as recombinant influenza vaccines for the prevention of influenza. The major factors that lead to the market growth include the need for annual vaccination and government initiatives to improve awareness about vaccination.
MRC’s analysts forecast the global influenza vaccine market to grow at a CAGR of 7.23% during the period 2018-2022.
Check the discount on the report at https://marketreportscenter.com/request-discount/573633
Covered in this report
The report covers the present scenario and the growth prospects of the global influenza vaccine market for 2018-2022. To calculate the market size, the report considers the revenue generated from the sales of influenza vaccine.
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
MRC's report, Global Influenza Vaccine Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
AstraZeneca
CSL
GlaxoSmithKline
Sanofi
Other prominent vendors
Altimmune
BionVax
FluGen
FOLIA BIOTECH
Genentech
Green Cross
Medicago
Moderna Therapeutics
Novavax
Shijiazhuang Yiling Pharmaceutical
SK Chemicals
UNM Pharma
Vaccitech
Vaxart
Vaxine Pty
Visterra.
Market driver
Rising awareness about influenza vaccination
For a full, detailed list, view our report
Market trend
Development of strong pipeline
For a full, detailed list, view our report
Review the summary and complete table of content at https://marketreportscenter.com/reports/573633/global-influenza-vaccine-market-2018-2022
About Market Reports Center;
Market Reports Center is an e-commerce platform obliging the needs of knowledge workers, experts, professionals who are subject to market research information for their work, or to make strategic business decisions. We are dedicated to create a comprehensive offering of market research which is accurate, credible and affordable.
Market Reports Center currently has more than 3,00,000 plus titles and 40+ Publishers on our platform and growing consistently. We cover more than 35 industry verticals being: Automotive, Electronics, Manufacturing, Pharmaceuticals, Healthcare, Chemicals, Construction, Agriculture, Food, Beverages, Banking & Finance, Media and Government, Public Sector Studies.
Connect for more details:
Sam Collins
Market Reports Center
1-646-883-3044 (US)
Email: info@marketreportscenter.com
Website: https://marketreportscenter.com
No comments:
Post a Comment